Differential expression of CA125 and a novel serum tumor marker HE4 in epithelial ovarian cancer

被引：4
作者：
Brown, A.
Miller, C.
Robison, K.
Somers, E.
Allard, J.
Granai, C. O.
Skates, S.
Bast, R. C., Jr.
Moore, R. G.
机构：
[1] Hartford Hosp, Hartford, CT 06115 USA
[2] Fujirebio Diagnost Inc, Malvern, PA USA
[3] Brown Univ, Women & Infants Hosp, Providence, RI USA
[4] Harvard Univ, Sch Med, Boston, MA USA
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.5533
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5533
引用
收藏
页数：1
相关论文
共 50 条
[21]   DISEASE RELAPSE IN OVARIAN CANCER PATIENTS DETECTED BY HE4 AND CA125 [J].
Steffensen, K. ;
Waldstrom, M. ;
Brandslund, I. ;
Lund, B. ;
Sorensen, S. M. ;
Petzold, M. ;
Jakobsen, A. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) :187-188
[22]   The clinical value of the combined detection of sEGFR, CA125 and HE4 for epithelial ovarian cancer diagnosis [J].
Li, Y. ;
Wang, Z. -C ;
Luo, L. ;
Mu, C. -Y. ;
Xu, J. ;
Feng, Q. ;
Li, S. -B. ;
Gu, B. ;
Ma, P. ;
Lan, T. .
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (02) :604-610
[23]   Role of Serum CA125 and HE4 in Predicting Optimal Cytoreduction in Advanced Epithelial Ovarian Cancer After Neoadjuvant Chemotherapy [J].
Pabashi Poddar ;
Shilpa Patel ;
Ruchi Arora .
Indian Journal of Gynecologic Oncology, 2023, 21
[24]   Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4 [J].
Ghose, Aruni ;
McCann, Lucy ;
Makker, Shania ;
Mukherjee, Uma ;
Gullapalli, Sri Vidya Niharika ;
Erekkath, Jayaraj ;
Shih, Stephanie ;
Mahajan, Ishika ;
Sanchez, Elisabet ;
Uccello, Mario ;
Moschetta, Michele ;
Adeleke, Sola ;
Boussios, Stergios .
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
[25]   Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer [J].
Andersen, M. Robyn ;
Goff, Barbara A. ;
Lowe, Kimberly A. ;
Scholler, Nathalie ;
Bergan, Lindsay ;
Drescher, Charles W. ;
Paley, Pamela ;
Urban, Nicole .
GYNECOLOGIC ONCOLOGY, 2010, 116 (03) :378-383
[26]   THE DIAGNOSTIC AND PROGNOSTIC VALUE OF HE4 AND CA125 IN OVARIAN CANCER PATIENTS [J].
Korse, Catharina M. ;
Bonfrer, J. M. G. ;
van Beurden, M. .
TUMOR BIOLOGY, 2010, 31 :S111-S111
[27]   HE4 combined with CA125: favorable screening tool for ovarian cancer [J].
Nasrin Ghasemi ;
Samira Ghobadzadeh ;
Mahnaz Zahraei ;
Hemn Mohammadpour ;
Salahadin Bahrami ;
Mohammad Bakhshi ganje ;
Shokoh Rajabi .
Medical Oncology, 2014, 31
[28]   Comparison of CA125, HE4, and ROMA index for ovarian cancer diagnosis [J].
Zhang, Lei ;
Chen, Ying ;
Wang, Ke .
CURRENT PROBLEMS IN CANCER, 2019, 43 (02) :135-144
[29]   Diagnostic and Prognostic Significance of CA125 and HE4 in Ovarian Cancer Patients [J].
Bandiera, E. ;
Romani, C. ;
Specchia, C. ;
Zanotti, L. ;
Belloli, S. ;
Bignotti, E. ;
Tassi, R. A. ;
Tognon, G. ;
Pecorelli, S. ;
Ravaggi, A. .
EUROPEAN JOURNAL OF CANCER, 2011, 47 :S539-S539
[30]   APPLICATION VALUE OF HE4, CA125 AND ROMA IN DIAGNOSIS OF THE OVARIAN CANCER [J].
Sun, Wenchao ;
Wang, Jinfang ;
Liu, Lubin .
ACTA MEDICA MEDITERRANEA, 2020, 36 (03) :1765-1769
12345